Status | Study |
Recruiting |
Study Name: Ceftaroline for Treatment of Hematogenously Acquired Staphylococcus Aureus Osteomyelitis in Children Condition: Hematogenously Acquired Staphylococcus Aureus Osteomyelitis Bone Infection Date: 2014-12-31 Interventions: Drug: Ceftaroline Fosamil IV Ceftaroline fosamil 15 mg/kg (or 600 mg if > 40 kg) infused over 120 ( |
Completed |
Study Name: Osteomyelitis: Procalcitonin to Diagnose and Monitor Osteomyelitis (PCT) Condition: Osteomyelitis Date: 2014-11-07 |
Recruiting |
Study Name: CERAMENT™|G - Bone Healing and Re-infection Prophylaxis Condition: Osteomyelitis Date: 2014-04-23 Interventions: Device: Cerament G |
Recruiting |
Study Name: Patients Response to Early Switch To Oral:Osteomyelitis Study Condition: Osteomyelitis Date: 2014-03-18 Interventions: Drug: oral antibiotics intrave |
Completed |
Study Name: Safety and Efficacy Study of Daptomycin Compared to Active Comparator in Pediatric Participants With Acute Hematogenous Osteomyelitis (AHO) (MK-3009-006) Condition: Acute Hematogenous Osteomyelitis Date: 2013-08-09 Interventions: Drug: Daptomycin Drug: Vancomycin (or equi |
Recruiting |
Study Name: CPP Bone Infection Registry Condition: Bone Infection Staphylococcus Aureus Date: 2012-08-29 |
Recruiting |
Study Name: Drug Penetration Into Bone After Repeated Oral Administration of Debio 1450 to Patients Undergoing Hip Replacement Surgery Condition: Date: 2024-05-05 |
Recruiting |
Study Name: Fosfomycin i.v. for Treatment of Severely Infected Patients Condition: Date: 2024-05-05 |
Active, not recruiting |
Study Name: Population Pharmacokinetic Analysis of Daptomycin in Patients With Osteoarticular Infections Condition: Date: 2024-05-05 |
Completed |
Study Name: Detection of Osteomyelitis Using High Resolution Ultrasound Condition: Date: 2024-05-05 |